wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38917848-964A6287-6CC0-48EE-8C11-A6FE55AB74D3
Q38917848-964A6287-6CC0-48EE-8C11-A6FE55AB74D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38917848-964A6287-6CC0-48EE-8C11-A6FE55AB74D3
Targeting indolent non-Hodgkin lymphoma.
P2860
Q38917848-964A6287-6CC0-48EE-8C11-A6FE55AB74D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38917848-964A6287-6CC0-48EE-8C11-A6FE55AB74D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a53cbd91c44b93c306d2bad7f7ac03e32aa5dc64
P2860
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+ lymphoid malignancies